The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study

BACKGROUND: Like other vaccines, Pfizer BioNTech’s COVID-19 vaccine efficacy against SARS-CoV-2 virus infections begins to decline within a few months after the 2(nd) dose. On August 12, 2021, the FDA allowed additional Pfizer BioNTch’s COVID-19 vaccine dose (3(rd) or booster dose) for individuals w...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Shitany, Nagla A, Bagher, Amina M, Binmahfouz, Lenah Saeed, Eid, Basma G, Almukadi, Haifa, Badr-Eldin, Shaimaa M, El-Hamamsy, Manal, Mohammedsaleh, Zuhair M, Saleh, Fayez M, Almuhayawi, Mohammed S, Alghamdi, Samar A, Arab, Rana A, Ali, Soad S, Harakeh, Steve, Alghamdi, Badrah S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426871/
https://www.ncbi.nlm.nih.gov/pubmed/36051568
http://dx.doi.org/10.2147/IJGM.S376316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426871/
https://www.ncbi.nlm.nih.gov/pubmed/36051568
http://dx.doi.org/10.2147/IJGM.S376316

Ejemplares similares